While LIF promotes tumor proliferation, chemoresistance, and immune suppression via JAK/STAT3, MAPK/ERK, and Hippo‐YAP signaling, its context‐dependent tumor‐suppressive roles add layers of complexity. The gene discussed is LIF; the disease is neoplasm.